Endurance Wealth Management’s Exact Sciences EXAS Stock Holding History

Endurance Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$477K	Sell	5,075 -750	-13%	-$58.5K	0.07%	127
2023 Q1	$395K	Sell	5,825 -950	-14%	-$61.1K	0.06%	141
2022 Q4	$336K	Sell	6,775 -140	-2%	-$5.72K	0.05%	142
2022 Q3	$224K	Sell	6,915 -200	-3%	-$8.25K	0.04%	173
2022 Q2	$281K	Sell	7,115 -850	-11%	-$45.5K	0.04%	166
2022 Q1	$557K	Buy	7,965 +950	+14%	+$69.4K	0.07%	126
2021 Q4	$546K	Buy	7,015 +2,515	+56%	+$222K	0.06%	140
2021 Q3	$429K	Buy	4,500 +1,550	+53%	+$164K	0.05%	159
2021 Q2	$366K	Buy	2,950 +800	+37%	+$95.5K	0.04%	172
2021 Q1	$284K	Buy	2,150 +350	+19%	+$47.9K	0.03%	189
2020 Q4	$239K	Hold	1,800	–	–	0.03%	190
2020 Q3	$184K	Buy	1,800 +1,400	+350%	+$121K	0.03%	189
2020 Q2	$35K	Sell	400 -600	-60%	-$47.9K	0.01%	348
2020 Q1	$58K	Buy	+1,000	New	+$81.2K	0.01%	263

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Endurance Wealth Management's EXAS Position: Q2 2023 in Review

Endurance Wealth Management reduced its Exact Sciences (EXAS) stake by 13% in Q2 2023, selling an estimated $58.5K and leaving 5,075 shares worth $477K. The position accounts for 0.07% of the portfolio, ranked #127.

Endurance Wealth Management first reported a position in EXAS in Q1 2020 and has held it in 14 quarters since. The position peaked at $557K in Q1 2022. 652 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

Endurance Wealth Management held 5,075 shares of Exact Sciences worth $477K as of Q2 2023.
Endurance Wealth Management sold 750 Exact Sciences shares in Q2 2023, an estimated $58.5K.
Exact Sciences made up 0.07% of Endurance Wealth Management's portfolio in Q2 2023, its #127 holding.
Endurance Wealth Management first reported a position in Exact Sciences in Q1 2020 and has held it in 14 quarters since.
Endurance Wealth Management's Exact Sciences position peaked at $557K in Q1 2022.
652 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.